The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ATR-101 phase 1 clinical study for adrenocortical carcinoma.
 
Aung Naing
Research Funding - Atterocor (Inst)
 
Siqing Fu
No Relationships to Disclose
 
Mouhammed Amir Habra
No Relationships to Disclose
 
Rashmi Chugh
No Relationships to Disclose
 
Electron Kebebew
Research Funding - Atterocor (Inst)
 
Jeffrey Russell
Research Funding - Atterocor (Inst)
 
Dawn Welshans
No Relationships to Disclose
 
Martin Fassnacht
Consulting or Advisory Role - Atterocor
Research Funding - Atterocor (Inst)
 
Matthias Kroiss
No Relationships to Disclose
 
Maria-Elisabeth Goebeler
No Relationships to Disclose
 
Marian Ijzerman
Employment - Atterocor
 
Marianne R Plaunt
Employment - Atterocor
 
Pharis Mohideen
Employment - Atterocor; Shionogi
Leadership - Atterocor
Stock and Other Ownership Interests - Atterocor
 
Martin Phillips
Employment - Atterocor
Stock and Other Ownership Interests - Atterocor
 
David C. Smith
Research Funding - Abraxis BioScience (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Oncogenex (Inst); OncoMed (Inst); PSMA Development Company (Inst); Tekmira (Inst); Teva (Inst)